CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

ASTH: Lowering target price to $37.00

Negative
AI Analysis

Summary

An analyst lowered Astellas Pharma's price target to $37.00, indicating a bearish view on the company's stock valuation.

Importance:2/10
Sentiment:
-0.50
price_targetanalyst_downgrade
Related Companies

Read the original article

Published by yahoo_finance on August 5, 2026 12:00 AM

Read Original